SCHEMBL9307589

SCHEMBL9307589

Cn1c2ccc(O)c(=O)c-2cc2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.58
KMT2A Q03164 3/20 0.58
MAPT P10636 3/20 0.58
ALDH1A1 P00352 3/20 0.58
HPGD P15428 2/20 0.58
MEN1 O00255 1/20 0.58
RECQL P46063 1/20 0.58
DAO P14920 1/20 0.57
MCL1 Q07820 1/20 0.45
BRD4 O60885 2/20 0.42
CA12 O43570 1/20 0.42
BRPF1 P55201 1/20 0.42
CA9 Q16790 1/20 0.42
KAT2B Q92831 1/20 0.42
BRD9 Q9H8M2 1/20 0.42
SLC9A1 P19634 1/20 0.39
HTT P42858 2/20 0.39
GLA P06280 2/20 0.38
GAA P10253 2/20 0.38
HSD17B10 Q99714 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18631541 0.81 KMT2A (0.47) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL2977751 0.81 KMT2A (0.47) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL11879067 0.81 MCL1 (0.53) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL5551751 0.79 KMT2A (0.45) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL195764 0.76 KMT2A (0.51) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL2967926 0.75 KMT2A (0.54) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL11553590 0.73 MAPT (1.00) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL11303565 0.73 DAO (0.68) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL1238984 0.73 DAO (1.00) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL10103705 0.71 KMT2A (0.76) KDM4EKMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5340818-A Treating leukemia with acridine-9-one derivative(glyfoline) SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1994-08-23 US disclosed